Ardelyx (ARDX) Amortizatization of Intangibles (2016 - 2026)
Ardelyx (ARDX) posted Amortizatization of Intangibles of $1.6 million for Q1 2026, down 23.98% on a QoQ basis from $2.1 million in Q4 2025, and down 25.94% year-over-year from $2.1 million in Q1 2025.
Ardelyx (ARDX) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Ardelyx's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 25.94% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.4 million (up 7.98% YoY) and the FY2025 annual result came in at $9.0 million, up 21.05% from the prior year.
- Amortizatization of Intangibles was $1.6 million for Q1 2026 at Ardelyx, down from $2.1 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.5 million in Q3 2025 and bottomed at $42000.0 in Q2 2022.
- A 5-year average of $1.4 million and a median of $1.6 million in 2026 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles tumbled 85.91% — and 2023, when it soared 2390.48%.
- Ardelyx's Amortizatization of Intangibles stood at $907000.0 in 2022, then increased by 24.26% to $1.1 million in 2023, then soared by 75.69% to $2.0 million in 2024, then grew by 5.1% to $2.1 million in 2025, then decreased by 23.98% to $1.6 million in 2026.
- Business Quant data shows ARDX's Amortizatization of Intangibles at $1.6 million in Q1 2026, $2.1 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Dec 31, 2023 | 1.13 Mn |